Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3579]

ASCO GU 2025: New findings on tumour reduction and survival outcomes in advanced renal cell carcinoma

ASCO GU 2025: New findings on tumour reduction and survival outcomes in advanced renal cell carcinoma

New hope for colorectal cancer treatment: Innovative CE6-GFFY photosensitizer shows promise in fighting tumors

New hope for colorectal cancer treatment: Innovative CE6-GFFY photosensitizer shows promise in fighting tumors

Massive data analysis advances the understanding of how immunotherapy works

Massive data analysis advances the understanding of how immunotherapy works

Study identifies immune response that may stop breast cancer from spreading

Study identifies immune response that may stop breast cancer from spreading

A self-assembling nanoplatform for enhanced cancer photoimmunotherapy

A self-assembling nanoplatform for enhanced cancer photoimmunotherapy

Radiation plus combination immunotherapy may help preserve bladder in some patients with muscle-invasive bladder cancer

Radiation plus combination immunotherapy may help preserve bladder in some patients with muscle-invasive bladder...

ASCO GU 2025: Some kidney cancer patients can stop combination treatment after two years

ASCO GU 2025: Some kidney cancer patients can stop combination treatment after two years

Immunotherapy against melanoma: efficacy can be predicted with a chip

Immunotherapy against melanoma: efficacy can be predicted with a chip

Innovative dual-target drug may lead to new investigational approach for breast cancer patients

Innovative dual-target drug may lead to new investigational approach for breast cancer patients

An enzyme to disarm tumours

An enzyme to disarm tumours

More from ecancer